Rare protein variant ‘could hold key to transforming breast cancer treatment’

Scientists hope further research will help translate the study’s findings into targeted therapies for breast cancer patients (Rui Vieira/PA)
Scientists hope further research will help translate the study’s findings into targeted therapies for breast cancer patients (Rui Vieira/PA)

A rare variant of a protein found in human cells may hold the key to transforming breast cancer treatment, scientists have said.

Experts believe that targeting this variant – called RAC1B – may “dramatically boost” treatment effectiveness.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited